Griffith University

MD, PhD

Lecturer Medical Education - Clinical Skills and Pathology

Contact details for Dr Ali Salajegheh

Biography

Dr Salajegheh undertook his medical degree at Tehran University of Medical Sciences in Iran. After receiving his MD, he was a research fellow at the Neurosurgery and Paediatrics departments in Tehran University Hospital as well as working as an emergency doctor and general practitioner in Iran. Ali is currently a Lecturer in Medical Education - Clinical Skills and Pathology with the School of Medicine, Griffith University and he is the Course Convenor of General Pathology for Bachelor of Dentistry and Oral Health. He completed his PhD in 2011 at Griffith University, School of Medicine.

Ali was recently nominated for Academic and Clinical Excellence awards for Clinical Skills Tutoring in School of Medicine. He has successfully applied for several grants and funding supports in the past few years and has presented the research he has done at Griffith University in over 20 national and international conferences. Ali’s principal area of research is Molecular Pathology and Medical Education. He currently has an active project looking at "Identification of genes involved in angiogenesis and metastasis” and is available to supervise HDR student projects on aspects of cancer, angiogenesis and metastasis.

Research interests

• Markers of angiogenesis
• Markers of metastasis
• Control of angiogenesis and metastasis
• Thyroid cancer molecular pathology            
• Colorectal cancer molecular pathology

Recognition and awards

• Dean of Learning and Teaching Commendation for Outstanding Performance Award - 2011
  

Publications

Refereed journal articles

• Freeman LM, Lam A, Petcu E, Smith R, Salajegheh A, Diamond P, Zannettino A, Evdokiou A, Luff J, Wong PF, Khalil D, Waterhouse N, Vari F, Rice AM, Catley L, Hart DN, Vuckovic S (2011) Myeloma-Induced Alloreactive T Cells Arising in Myeloma-Infiltrated Bones Include Double-Positive CD8+CD4+ T Cells: Evidence from Myeloma-Bearing Mouse Model. Journal of  Immunology. 187: 3987-3996.
• Salajegheh A, Smith RA, Kasem K, Gopalan V, Nassiri MR, William R, Lam AKY (2011) Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: Potential markers for aggressive phenotypes. European Journal of Surgical Oncology (EJSO). 37(1): 93-99.
• Smith RA, Salajegheh A, Weinstein S, Nassiri M, Lam AK (2011) Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant. Human Pathology. 42(4):500-506.
• Gopalan V, Smith RA, Nassiri MR, Yasuda K, Salajegheh A, Kim SY, Ho YH, Weinstein S, Tang JC, Lam AK (2010) GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features. Human Pathology. 41(7):1009-1015.
• Salajegheh A, Petcu EB, Smith RA, Lam AKY (2008) Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists. Postgrad Med Journal. 84(988):78-82.

Refereed conference papers

• Kasem KY, Gopalan V, Salajegheh A, Smith RA, Lam AKY (2010) Expression of JK1 Gene in Colorectal Adenocarcinoma. Virchows Archives. 457(2): 165-166.
• Gopalan V, Salajegheh A, Nassiri MR, Smith RA, Lam AKY (2010) Novel oncogene GAEC1: Involved in pathogenesis and potential use in differential diagnosis of tumours. Pathology. 42, S71.
• Lam AKY, Smith RA, Salajegheh A, Ho YH (2008) Increased expression and correlations of survivin and telomerase activity in colorectal adenocarcinoma. Pathology International. 58(11): A3-4.
  

Non-refereed conference papers (international)

• Smith RA, Salajegheh A, Weinstein S, Lam AKY. BRAF mutation in papillary thyroid carcinoma: new angles for an old foe. 35th Annual Scientific Meeting of the International Academy of Pathology, Australasian Division, Sydney, Australia. June 2010.
• Kasem KY, Gopalan V, Salajegheh A, Smith RA, Lam AKY. Expression of JK1 Gene in Colorectal Adenocarcinoma. In: Canadian Human Genetics Conference. Quebec, Canada. April 2010.
• Salajegheh A, Smith RA, Lam AKY. Potential roles of miRNAs and SNPs in angiogenic event in thyroid cancer. In: Association for International Cancer Research (AICR) 30th anniversary conference, St. Andrews, Fife, Scotland, UK. April 2010.
• Gopalan V, Salajegheh A, Nassiri MR, Smith RA, Lam AKY. Novel oncogene GAEC1: Involved in pathogenesis and potential use in differential diagnosis of tumours. Pathology update. Melbourne, Australia. May 2010.
• Salajegheh A, Nassiri MR, Disanayake JK, Kim SY, Gopalan V, DaSilva D, Le T, Smith R, Lam A. The Role of VEGF Polymorphism in Molecular Diagnosis of Thyroid Cancer. 4th Medical Biotech Forum. Dalian, China. August 2009.
• Lam AKY, Salajegheh A, DaSilva D, Lam T, Petcu E, Zou Y, Nassiri MR, Smith R. BRAF Mutation: Application in Thyroid Cancer Diagnosis. 4th Medical Biotech Forum. Dalian, China. August 2009.
• Salajegheh A, Smith RA, Lam AK. The prevalence of vascular endothelial growth factor -141A/C polymorphism in papillary thyroid carcinoma and its potential as a marker for tissue invasiveness [abstract]. In: Proceedings of the 100th Annual Meeting of the American Association for Cancer Research. Denver, Philadelphia USA. 2009. Abstract number 4071. April 2009.
• Gopalan V, Kim SY, Salajegheh A, Tang JC, Smith RA, Lam AK. Detection of the GAEC1 oncogene in benign and malignant colorectal tissue: a pilot study of a novel gene. Proceedings of the 100th Annual Meeting of the American Association for Cancer Research. Denver, Philadelphia USA. 2009. Abstract number 1353. April 2009.
  

Current teaching areas

• Pathology
  
• Clinical skills workshop
• PBL tutoring